Interleukin 9: Difference between revisions
Content deleted Content added
No edit summary |
Reverted 1 edit by Mimi 822 453 233 (talk): Unexplained removal of content. (TW) |
||
| Line 1: | Line 1: | ||
{{PBB|geneid=3578}} |
{{PBB|geneid=3578}} |
||
| ⚫ | '''Interleukin 9''', also known as '''IL-9''', is a [[cytokine]] (cell signalling molecule) belonging to the group of [[interleukin]]s.<ref name="entrez">{{cite web | title = Entrez Gene: IL9 interleukin 9| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3578| accessdate = }}</ref> |
||
| ⚫ | '''Interleukin 9''' |
||
== Function == |
== Function == |
||
The protein encoded by this gene is a [[cytokine]] produced by [[T-cells]] and specifically by [[CD4+ helper cells]] that acts as a regulator of a variety of [[hematopoietic cell]]s. This cytokine stimulates [[cell proliferation]] and prevents [[apoptosis]]. It functions through the [[interleukin-9 receptor]] (IL9R), which activates different signal transducer and activator ([[STAT protein|STAT]]) proteins and thus connects this cytokine to various biological processes. The gene encoding this cytokine has been identified as a candidate gene for [[asthma]]. Genetic studies on a mouse model of asthma demonstrated that this cytokine is a determining factor in the pathogenesis of [[bronchial hyperresponsiveness]].<ref name="entrez" /> |
|||
Interleukin |
Interleukin-9 has also shown to inhibit [[melanoma]] growth in mice.<ref name="pmid22772464">{{cite journal | author = Purwar R, Schlapbach C, Xiao S, Kang HS, Elyaman W, Jiang X, Jetten AM, Khoury SJ, Fuhlbrigge RC, Kuchroo VK, Clark RA, Kupper TS | title = Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells | journal = Nat. Med. | volume = 18| issue = 8| pages = 1248–53|date=July 2012 | pmid = 22772464 | pmc = 3518666 | doi = 10.1038/nm.2856 | laysummary = http://medicalxpress.com/news/2012-07-scientists-molecule-immune-dangerous-skin.html | laysource = medicalxpress.com }}</ref> |
||
== References == |
== References == |
||
| Line 22: | Line 21: | ||
*{{cite journal |vauthors=Renauld JC, Goethals A, Houssiau F, etal |title=Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene |journal=J. Immunol. |volume=144 |issue= 11 |pages= 4235–41 |year= 1990 |pmid= 1971295 |doi= }} |
*{{cite journal |vauthors=Renauld JC, Goethals A, Houssiau F, etal |title=Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene |journal=J. Immunol. |volume=144 |issue= 11 |pages= 4235–41 |year= 1990 |pmid= 1971295 |doi= }} |
||
*{{cite journal |vauthors=Renauld JC, Goethals A, Houssiau F, etal |title=Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40 |journal=Cytokine |volume=2 |issue= 1 |pages= 9–12 |year= 1991 |pmid= 2129501 |doi=10.1016/1043-4666(90)90037-T }} |
*{{cite journal |vauthors=Renauld JC, Goethals A, Houssiau F, etal |title=Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40 |journal=Cytokine |volume=2 |issue= 1 |pages= 9–12 |year= 1991 |pmid= 2129501 |doi=10.1016/1043-4666(90)90037-T }} |
||
*{{cite journal |vauthors=Yang YC, Ricciardi S, Ciarletta A, etal |title=Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of |
*{{cite journal |vauthors=Yang YC, Ricciardi S, Ciarletta A, etal |title=Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40 |journal=Blood |volume=74 |issue= 6 |pages= 1880–4 |year= 1989 |pmid= 2508790 |doi= }} |
||
*{{cite journal |vauthors=Yin T, Keller SR, Quelle FW, etal |title=Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases |journal=J. Biol. Chem. |volume=270 |issue= 35 |pages= 20497–502 |year= 1995 |pmid= 7544789 |doi=10.1074/jbc.270.35.20497 }} |
|||
*{{cite journal |vauthors=Postma DS, Bleecker ER, Amelung PJ, etal |title=Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy |journal=N. Engl. J. Med. |volume=333 |issue= 14 |pages= 894–900 |year= 1995 |pmid= 7666875 |doi=10.1056/NEJM199510053331402 }} |
|||
*{{cite journal |vauthors=Le Beau MM, Espinosa R, Neuman WL, etal |title=Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=90 |issue= 12 |pages= 5484–8 |year= 1993 |pmid= 8516290 |doi=10.1073/pnas.90.12.5484 | pmc=46745 }} |
|||
*{{cite journal |vauthors=Demoulin JB, Uyttenhove C, Van Roost E, etal |title=A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9 |journal=Mol. Cell. Biol. |volume=16 |issue= 9 |pages= 4710–6 |year= 1996 |pmid= 8756628 |doi= | pmc=231471 }} |
|||
*{{cite journal |vauthors=Nicolaides NC, Holroyd KJ, Ewart SL, etal |title=Interleukin 9: A candidate gene for asthma |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=94 |issue= 24 |pages= 13175–80 |year= 1998 |pmid= 9371819 |doi=10.1073/pnas.94.24.13175 | pmc=24282 }} |
|||
*{{cite journal |vauthors=Demoulin JB, Van Roost E, Stevens M, etal |title=Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9 |journal=J. Biol. Chem. |volume=274 |issue= 36 |pages= 25855–61 |year= 1999 |pmid= 10464327 |doi=10.1074/jbc.274.36.25855 }} |
|||
*{{cite journal | author=Lejeune D, Demoulin JB, Renauld JC |title=Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling |journal=Biochem. J. |volume=353 |issue= Pt 1 |pages= 109–116 |year= 2001 |pmid= 11115404 |doi=10.1042/0264-6021:3530109 | pmc=1221548 }} |
|||
*{{cite journal | author=Little FF, Cruikshank WW, Center DM |title=Il-9 stimulates release of chemotactic factors from human bronchial epithelial cells |journal=Am. J. Respir. Cell Mol. Biol. |volume=25 |issue= 3 |pages= 347–52 |year= 2001 |pmid= 11588013 |doi= 10.1165/ajrcmb.25.3.4349}} |
|||
*{{cite journal | author=Toda M, Tulic MK, Levitt RC, Hamid Q |title=A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma |journal=J. Allergy Clin. Immunol. |volume=109 |issue= 2 |pages= 246–50 |year= 2002 |pmid= 11842292 |doi=10.1067/mai.2002.121555 }} |
|||
*{{cite journal |vauthors=Pilette C, Ouadrhiri Y, Van Snick J, etal |title=IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta |journal=J. Immunol. |volume=168 |issue= 8 |pages= 4103–11 |year= 2002 |pmid= 11937570 |doi= 10.4049/jimmunol.168.8.4103}} |
|||
{{refend}} |
|||
{{interleukins}} |
|||
{{gene-5-stub}} |
|||
{{immunology-stub}} |
|||
Revision as of 21:02, 4 April 2016
Template:PBB Interleukin 9, also known as IL-9, is a cytokine (cell signalling molecule) belonging to the group of interleukins.[1]
Function
The protein encoded by this gene is a cytokine produced by T-cells and specifically by CD4+ helper cells that acts as a regulator of a variety of hematopoietic cells. This cytokine stimulates cell proliferation and prevents apoptosis. It functions through the interleukin-9 receptor (IL9R), which activates different signal transducer and activator (STAT) proteins and thus connects this cytokine to various biological processes. The gene encoding this cytokine has been identified as a candidate gene for asthma. Genetic studies on a mouse model of asthma demonstrated that this cytokine is a determining factor in the pathogenesis of bronchial hyperresponsiveness.[1]
Interleukin-9 has also shown to inhibit melanoma growth in mice.[2]
References
- ^ a b "Entrez Gene: IL9 interleukin 9".
- ^ Purwar R, Schlapbach C, Xiao S, Kang HS, Elyaman W, Jiang X, Jetten AM, Khoury SJ, Fuhlbrigge RC, Kuchroo VK, Clark RA, Kupper TS (July 2012). "Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells". Nat. Med. 18 (8): 1248–53. doi:10.1038/nm.2856. PMC 3518666. PMID 22772464.
{{cite journal}}: Unknown parameter|laysource=ignored (help); Unknown parameter|laysummary=ignored (help)CS1 maint: multiple names: authors list (link)
Further reading
- Renauld JC, Houssiau F, Louahed J, et al. (1993). "Interleukin-9". Adv. Immunol. Advances in Immunology. 54: 79–97. doi:10.1016/S0065-2776(08)60533-7. ISBN 978-0-12-022454-8. PMID 8379467.
- Knoops L, Renauld JC (2005). "IL-9 and its receptor: from signal transduction to tumorigenesis". Growth Factors. 22 (4): 207–15. doi:10.1080/08977190410001720879. PMID 15621723.
- Modi WS, Pollock DD, Mock BA, et al. (1991). "Regional localization of the human glutaminase (GLS) and interleukin-9 (IL9) genes by in situ hybridization". Cytogenet. Cell Genet. 57 (2–3): 114–6. doi:10.1159/000133126. PMID 1680606.
- Kelleher K, Bean K, Clark SC, et al. (1991). "Human interleukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-I-transformed human T cells". Blood. 77 (7): 1436–41. PMID 1901233.
- Holbrook ST, Ohls RK, Schibler KR, et al. (1991). "Effect of interleukin-9 on clonogenic maturation and cell-cycle status of fetal and adult hematopoietic progenitors". Blood. 77 (10): 2129–34. PMID 1903074.
- Merz H, Houssiau FA, Orscheschek K, et al. (1991). "Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma". Blood. 78 (5): 1311–7. PMID 1908723.
- Renauld JC, Goethals A, Houssiau F, et al. (1990). "Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene". J. Immunol. 144 (11): 4235–41. PMID 1971295.
- Renauld JC, Goethals A, Houssiau F, et al. (1991). "Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40". Cytokine. 2 (1): 9–12. doi:10.1016/1043-4666(90)90037-T. PMID 2129501.
- Yang YC, Ricciardi S, Ciarletta A, et al. (1989). "Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40". Blood. 74 (6): 1880–4. PMID 2508790.
- Yin T, Keller SR, Quelle FW, et al. (1995). "Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases". J. Biol. Chem. 270 (35): 20497–502. doi:10.1074/jbc.270.35.20497. PMID 7544789.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - Postma DS, Bleecker ER, Amelung PJ, et al. (1995). "Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy". N. Engl. J. Med. 333 (14): 894–900. doi:10.1056/NEJM199510053331402. PMID 7666875.
- Le Beau MM, Espinosa R, Neuman WL, et al. (1993). "Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases". Proc. Natl. Acad. Sci. U.S.A. 90 (12): 5484–8. doi:10.1073/pnas.90.12.5484. PMC 46745. PMID 8516290.
- Demoulin JB, Uyttenhove C, Van Roost E, et al. (1996). "A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9". Mol. Cell. Biol. 16 (9): 4710–6. PMC 231471. PMID 8756628.
- Nicolaides NC, Holroyd KJ, Ewart SL, et al. (1998). "Interleukin 9: A candidate gene for asthma". Proc. Natl. Acad. Sci. U.S.A. 94 (24): 13175–80. doi:10.1073/pnas.94.24.13175. PMC 24282. PMID 9371819.
- Demoulin JB, Van Roost E, Stevens M, et al. (1999). "Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9". J. Biol. Chem. 274 (36): 25855–61. doi:10.1074/jbc.274.36.25855. PMID 10464327.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - Lejeune D, Demoulin JB, Renauld JC (2001). "Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling". Biochem. J. 353 (Pt 1): 109–116. doi:10.1042/0264-6021:3530109. PMC 1221548. PMID 11115404.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - Little FF, Cruikshank WW, Center DM (2001). "Il-9 stimulates release of chemotactic factors from human bronchial epithelial cells". Am. J. Respir. Cell Mol. Biol. 25 (3): 347–52. doi:10.1165/ajrcmb.25.3.4349. PMID 11588013.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - Toda M, Tulic MK, Levitt RC, Hamid Q (2002). "A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma". J. Allergy Clin. Immunol. 109 (2): 246–50. doi:10.1067/mai.2002.121555. PMID 11842292.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - Pilette C, Ouadrhiri Y, Van Snick J, et al. (2002). "IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta". J. Immunol. 168 (8): 4103–11. doi:10.4049/jimmunol.168.8.4103. PMID 11937570.
 | This article on a gene on human chromosome 5 is a stub. You can help Wikipedia by expanding it. |
 | This immunology article is a stub. You can help Wikipedia by expanding it. |